Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has been recommended as a long term growth pick according to Beta Research. With their stock price currently trading around $384.80, the firm has proven a solid track record of growth over the past few years. Investors might consider the stock as a long term growth candidate as the firm has yielded 38.80% earnings per share growth over the past 5 years and 61.30% revenue growth over that same time frame.
Let’s take a look at how the stock has been performing recently. Over the past twelve months, Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)’s stock was 4.82%. Over the last week of the month, it was -4.84%, -17.87% over the last quarter, and -13.86% for the past six months.
Over the past 50 days, Regeneron Pharmaceuticals, Inc.’s stock is -23.58% off of the high and -1.64% removed from the low. Their 52-Week High and Low are as follows: -29.21% (High), 13.15%, (Low).
Despite the past success, investors want to know where the stock is headed from here. Analysts covering the shares have a consensus short-term price target of $488.22 on the equity. Analysts have a consensus recommendation of 2.30 based on a 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples. They should not be utilized to make stock portfolio or financial decisions as they are based only on limited and open source information. Assumptions made within the analysis are not reflective of the position of any analysts or financial professionals.